These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

442 related articles for article (PubMed ID: 11950918)

  • 41. A new Mel-CAM (CD146)-specific monoclonal antibody, MN-4, on paraffin-embedded tissue.
    Shih IM; Nesbit M; Herlyn M; Kurman RJ
    Mod Pathol; 1998 Nov; 11(11):1098-106. PubMed ID: 9831208
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Histomorphometrical study in cavernous lymphangioma of the tongue.
    Yaita T; Onodera K; Xu H; Ooya K
    Oral Dis; 2007 Jan; 13(1):99-104. PubMed ID: 17241438
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Lymphatic and vascular origin of Kaposi's sarcoma spindle cells during tumor development.
    Pyakurel P; Pak F; Mwakigonja AR; Kaaya E; Heiden T; Biberfeld P
    Int J Cancer; 2006 Sep; 119(6):1262-7. PubMed ID: 16615115
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Podoplanin: a novel diagnostic immunohistochemical marker.
    Ordóñez NG
    Adv Anat Pathol; 2006 Mar; 13(2):83-8. PubMed ID: 16670463
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Differential expression of active mitogen-activated protein kinase in cutaneous endothelial neoplasms: implications for biologic behavior and response to therapy.
    Arbiser JL; Weiss SW; Arbiser ZK; Bravo F; Govindajaran B; Caceres-Rios H; Cotsonis G; Recavarren S; Swerlick RA; Cohen C
    J Am Acad Dermatol; 2001 Feb; 44(2):193-7. PubMed ID: 11174372
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Cutaneous immunoreactivity of D2-40 antibody beyond the lymphatics.
    Gomaa AH; Yaar M; Bhawan J
    Am J Dermatopathol; 2007 Feb; 29(1):18-21. PubMed ID: 17284957
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Detection of lymphatic invasion in primary melanoma with monoclonal antibody D2-40: a new selective immunohistochemical marker of lymphatic endothelium.
    Niakosari F; Kahn HJ; Marks A; From L
    Arch Dermatol; 2005 Apr; 141(4):440-4. PubMed ID: 15837861
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Inducible expression of MS-1 high-molecular-weight protein by endothelial cells of continuous origin and by dendritic cells/macrophages in vivo and in vitro.
    Goerdt S; Bhardwaj R; Sorg C
    Am J Pathol; 1993 May; 142(5):1409-22. PubMed ID: 8494045
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The transcription factor Prox1 is a marker for lymphatic endothelial cells in normal and diseased human tissues.
    Wilting J; Papoutsi M; Christ B; Nicolaides KH; von Kaisenberg CS; Borges J; Stark GB; Alitalo K; Tomarev SI; Niemeyer C; Rössler J
    FASEB J; 2002 Aug; 16(10):1271-3. PubMed ID: 12060670
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Production of two novel monoclonal antibodies that distinguish mouse lymphatic and blood vascular endothelial cells.
    Ezaki T; Kuwahara K; Morikawa S; Shimizu K; Sakaguchi N; Matsushima K; Matsuno K
    Anat Embryol (Berl); 2006 Oct; 211(5):379-93. PubMed ID: 16685512
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Comparative analysis of D2-40 and LYVE-1 immunostaining in lymphatic malformations.
    Florez-Vargas A; Vargas SO; Debelenko LV; Perez-Atayde AR; Archibald T; Kozakewich HP; Zurakowski D
    Lymphology; 2008 Sep; 41(3):103-10. PubMed ID: 19013877
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Prox1 transcription factor as a marker for vascular tumors-evaluation of 314 vascular endothelial and 1086 nonvascular tumors.
    Miettinen M; Wang ZF
    Am J Surg Pathol; 2012 Mar; 36(3):351-9. PubMed ID: 22067331
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Expression of Fli-1, a nuclear transcription factor, distinguishes vascular neoplasms from potential mimics.
    Folpe AL; Chand EM; Goldblum JR; Weiss SW
    Am J Surg Pathol; 2001 Aug; 25(8):1061-6. PubMed ID: 11474291
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Evidence for the origin of Kaposi's sarcoma from lymphatic endothelium.
    Beckstead JH; Wood GS; Fletcher V
    Am J Pathol; 1985 May; 119(2):294-300. PubMed ID: 2986460
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Kaposi's sarcoma: evidence supporting its origin from the lymphatic system.
    Dorfman RF
    Lymphology; 1988 Mar; 21(1):45-52. PubMed ID: 3294514
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A series of vascular tumors and tumorlike lesions of the bladder.
    Tavora F; Montgomery E; Epstein JI
    Am J Surg Pathol; 2008 Aug; 32(8):1213-9. PubMed ID: 18580491
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Significance of periductal lymphatic and blood vascular densities in intraductal carcinoma of the breast.
    El-Gohary YM; Metwally G; Saad RS; Robinson MJ; Mesko T; Poppiti RJ
    Breast J; 2009; 15(3):261-7. PubMed ID: 19645781
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Growth hormone in vascular pathology: neovascularization and expression of receptors is associated with cellular proliferation.
    Lincoln DT; Singal PK; Al-Banaw A
    Anticancer Res; 2007; 27(6B):4201-18. PubMed ID: 18225592
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Differential Prox-1 and CD 31 expression in mucousae, cutaneous and soft tissue vascular lesions and tumors.
    Reis RM; Reis-Filho JS; Longatto Filho A; Tomarev S; Silva P; Lopes JM
    Pathol Res Pract; 2005; 201(12):771-6. PubMed ID: 16308102
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Desmoplakin and Plakoglobin--specific markers of lymphatic vessels in the skin?
    Fedele C; Berens D; Rautenfeld V; Pabst R
    Anat Histol Embryol; 2004 Jun; 33(3):168-71. PubMed ID: 15144286
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.